THRIVE EARLIER DETECTION
Thrive is a healthcare company focused on saving lives by making earlier detection of cancer a routine part of medical care. It develops CancerSEEK, a liquid biopsy test that is designed to detect many cancers at earlier stages of the disease. CancerSEEK will serve as the core of Thrive’s integrated cancer information offering. The company was launched in 2019 by Third Rock Ventures, with funding from additional investors Section 32, Casdin Capital, Biomatics Capital, BlueCross BlueShield Venture Partners, The Invus Group, Camden Partners Nexus, Cowin Venture, Exact Sciences, and Gamma3.
THRIVE EARLIER DETECTION
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2019-05-30
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.thrivedetect.com
Total Employee:
101+
Status:
Active
Contact:
760-904-0467
Email Addresses:
[email protected]
Total Funding:
367 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail Cloudflare Google Google Cloud COVID-19 Amazon Route 53 Ruby On Rails Token
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Helio Health
Helio Health is an AI-driven healthcare company that commercializes early cancer detection tests from a simple blood draw.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Syantra
Syantra is a precision healthcare company that focuses on the commercialization of breast cancer detection blood tests.
Current Advisors List
Current Employees Featured
Founder
Investors List
BlueCross BlueShield Venture Partners
BlueCross BlueShield Venture Partners investment in Series B - Thrive Earlier Detection
Exact Sciences
Exact Sciences investment in Series B - Thrive Earlier Detection
Sands Capital Ventures
Sands Capital Ventures investment in Series B - Thrive Earlier Detection
Lux Capital
Lux Capital investment in Series B - Thrive Earlier Detection
Janus Henderson Investors
Janus Henderson Investors investment in Series B - Thrive Earlier Detection
Driehaus Capital Management
Driehaus Capital Management investment in Series B - Thrive Earlier Detection
T. Rowe Price
T. Rowe Price investment in Series B - Thrive Earlier Detection
Perceptive Advisors
Perceptive Advisors investment in Series B - Thrive Earlier Detection
Third Rock Ventures
Third Rock Ventures investment in Series B - Thrive Earlier Detection
Brown Advisory
Brown Advisory investment in Series B - Thrive Earlier Detection
Official Site Inspections
http://www.thrivedetect.com
- Host name: 39.128.237.35.bc.googleusercontent.com
- IP address: 35.237.128.39
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
